AI処方コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方審査アシスタント

${:__('collect %s',処方審査アシスタント)}$

医療健康

患者の病歴と使用記録に基づき、潜在的な薬物相互作用や禁忌症を自動で特定し、標準化された審査レポートを生成します。

プロンプト内容

コピー

Act as a senior clinical pharmacist and perform a comprehensive prescription review based on the provided patient electronic health record data, including medical history, allergy history, current medication list, and the newly prescribed medication. Focus on analyzing potential pharmacokinetic or pharmacodynamic interactions between the new prescription and existing drugs, assess dose adjustment needs based on hepatic or renal function, and check for any known absolute contraindications. Output a structured audit result clearly indicating the risk level, specific interaction mechanisms, and recommended alternative solutions or dosage adjustment strategies to ensure medication safety.

コピー

シニア臨床薬剤師として振る舞い、提供された患者の電子健康記録データ（既往歴、アレルギー歴、現在の薬剤リスト、および新規処方）に基づいて包括的な処方の妥当性審査を実行してください。新規処方薬と既存の薬物の間の薬物動態学または薬力学的相互作用の可能性に重点を置き、肝機能や腎機能に基づいた用量調整の必要性を評価し、既知の絶対禁忌症がないか確認してください。リスクレベル、具体的な相互作用メカニズム、および推奨される代替案や用量調整戦略を明確に示す構造化された審査結果を出力し、投薬の安全性を確保してください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug interactions, contraindication conflicts, and whether dosages align with the patient's age and hepatic/renal function status. Identify any risk points according to the latest clinical guidelines, and finally provide a clear audit conclusion with adjustment recommendations.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for drug-drug interactions, contraindications, and dosage adjustments for special populations (e.g., hepatic or renal impairment). Finally, if any potential risks or inappropriate usage are identified, clearly specify the issues and provide evidence-based optimization suggestions or alternative regimens, ensuring the output is objective, professional, and compliant with medical safety standards.

処方箋審査アシスタント

Act as a clinical pharmacist and review the prescribed medication list against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing potential drug-drug interactions, checking if dosages exceed safety limits, identifying incompatibilities, and verifying compliance with specific physiological conditions such as renal impairment or pregnancy. Output a detailed audit report highlighting any identified risks and provide evidence-based alternative suggestions or dosage adjustments to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.

術後リハビリアシスタント

Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.